Caroline Dent
Nurse Practitioner · Cartersville, GANPI 1396325726
Payments from drug & device makers
Across 115 payments — averaging $19.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$382
- Novo Nordisk$292
- Lilly USA, LLC$276
- GSK$150
- Pfizer$133
- Shield Therapeutics Inc$107
- plus $855 from 18 others
What the payments were for
- Food & beverage$2,196100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $382 |
| Novo Nordisk | 16 | $292 |
| Lilly USA, LLC | 16 | $276 |
| GSK | 9 | $150 |
| Pfizer | 8 | $133 |
| Shield Therapeutics Inc | 5 | $107 |
| Sumitomo Pharma America, Inc. | 3 | $100 |
| Dexcom, Inc. | 3 | $96 |
| Amgen | 5 | $80 |
| Bayer | 4 | $78 |
| Phathom Pharmaceuticals, Inc. | 4 | $77 |
| Johnson & Johnson | 3 | $63 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Boehringer Ingelheim | 2 | $46 |
| AstraZeneca | 3 | $43 |
| Astellas Pharma US Inc | 2 | $37 |
| Idorsia Pharmaceuticals US Inc | 2 | $35 |
| Boston Scientific | 2 | $34 |
| Optinose US, Inc. | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Neos Therapeutics, LP | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
How this compares
$2,196 in reported general payments places this provider in the 85th percentile of 3,328 nurse practitioner providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 23 | $26,933 |
| OzempicSemaglutide | 19 | $25,675 |
| MounjaroTirzepatide | 15 | $21,833 |
| MyrbetriqMirabegron | 14 | $14,740 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $6,643 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 73 | $1,819 |
| Levothyroxine Sodium | 144 | $1,364 |
| Pantoprazole Sodium | 77 | $936 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 12 | $902 |
| Potassium Chloride | 20 | $839 |
| Atorvastatin Calcium | 125 | $835 |
| Amlodipine-AtorvastatinAmlodipine/Atorvastatin | 13 | $786 |
| Rosuvastatin Calcium | 79 | $751 |
| Gabapentin | 47 | $733 |
| Omeprazole | 59 | $663 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $46 | $26,93323 claims |
| Novo NordiskOzempic | $292 | $25,67519 claims |
| Lilly USA, LLCMounjaro | $276 | $21,83315 claims |
| Astellas Pharma US IncMyrbetriq | $37 | $14,74014 claims |
| GSKAnoro Ellipta | $150 | $6,64313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Cartersville
- Crystal LogsdonSavannah$566K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Pamela AllenRome$270K
- Tajuana BradleyJohns Creek$256K
- Janice McAlisterAtlanta$241K
- Jessica AdkinsSavannah$226K
- Laura ElledgeAtlanta$177K
- Afsha HussainiKennesaw$122K
- Elizabeth TyeAlbany$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.